Johnson & Johnson expects full-year earnings in the range of $10.50 to $10.70 per share, with revenue in the range of $89.2 billion to $90 billion. This story was generated by Automated Insights ( ...

In the latest trading session, Johnson & Johnson (JNJ) closed at $147.77, marking a +1.93% move from the previous day. The stock's performance was ahead of the S&P 500's daily loss of 0.21%. Elsewhere ...

Johnson & Johnson’s stock dropped more than 3% Wednesday after the medical-technology and drug company beat estimates for the fourth quarter but as lower sales guidance for the year stoked fears of ...

Johnson & Johnson beat Wall Street’s fourth-quarter expectations as strong cancer drug sales compensated for a decline in demand for the company’s blockbuster psoriasis treatment.

Johnson & Johnson has won Food and Drug Administration ... patients with generalized myasthenia gravis. The New Brunswick, N.J., pharmaceutical giant on Thursday said nipocalimab, if approved ...

Both these factors can be tied in part to J&J’s strong presence in the consumer sector – but behind household name products is a ... s long and varied history. Johnson & Johnson was founded ...

Andrew Garbarino (R-N.Y.), co-chair ... natural gas products, have made fueling up at the gas station and cooling or heating homes astronomically more expensive,” Johnson said.

Speaker Mike Johnson had appeared to be on a glide path ... Democrats across the country are looking for in our next D.N.C. chair,” Schumer said in a statement. “He’s a tenacious organizer ...

This wine won the award for best white wine in the institutional sector at the 2024 Korea Liquor Awards. The importer is Le ...

The CDC recommends disinfecting things with a chlorine bleach solution or one of the products listed on this Environmental ..

Analyst Tim Anderson of Bank of America Securities reiterated a Hold rating on Johnson & Johnson (JNJ – Research Report), reducing the ...